Cabozantinib 40mg tablets
NHS hospitals in England used £42,820,606 of indicative cost of Cabozantinib 40mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 15.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Cabozantinib 40mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Cabozantinib 40mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £3,013,969 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,837,736 |
| South Tyneside And Sunderland Nhs Ft | £1,926,911 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,903,081 |
| Royal Surrey County Hosp Nhs Found Trust | £1,711,590 |
| The Royal Marsden Nhs Foundation Trust | £1,277,511 |
| Leeds Teaching Hpls Nhs Trust | £1,263,292 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,232,606 |
| Sheffield Teaching Hospitals Nhs Trust | £1,126,317 |
| Nottingham University Hospitals Trust | £1,031,343 |
The primary-care picture
Cabozantinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Cabozantinib medicine page.